- Report
- February 2025
- 135 Pages
Global
From €3475EUR$3,999USD£3,025GBP
- Report
- December 2024
- 200 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- November 2023
- 190 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- July 2023
- 78 Pages
United States
From €3042EUR$3,500USD£2,647GBP
- Report
- January 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- December 2024
- 200 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- October 2024
- 200 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- October 2024
- 200 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- January 2024
- 200 Pages
Global
From €3607EUR$4,150USD£3,139GBP
- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 150 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- July 2024
- 120 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2024
- 120 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- April 2023
- 134 Pages
Global
From €4128EUR$4,750USD£3,593GBP
From €3129EUR$3,600USD£2,723GBP
- Report
- May 2024
North America
From €1304EUR$1,500USD£1,135GBP
- Report
- May 2024
Asia Pacific
From €1304EUR$1,500USD£1,135GBP
- Report
- May 2024
Middle East, Africa
From €1304EUR$1,500USD£1,135GBP
- Report
- December 2024
- 146 Pages
Global
From €2575EUR$2,963USD£2,241GBP
€3433EUR$3,950USD£2,988GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more